98 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
innovation and ultimate replenishment of pipeline. Ultimately drives revenue growth from new products. 3-year Relative TSR Modifier +/-30% points Aligns payout
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
impacts on patients and society. Biopharmaceutical innovation is diverse and widely dispersed around the world. In the past five years, there have been … countries1. That is a remarkable flow of innovation and it is imperative that it is protected. The industry cannot thrive and deliver medicines where
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:24am
and Chief Executive Officer, Alnylam Pharmaceuticals, Inc. June 2017 Chairperson, Biotechnology Innovation Organization November 2021 External Director, Beam … insights into the leveraging of technology to drive innovation and create value. Having worked with companies across Asia, Europe, and North America, she
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:01am
and technology to make our business operations more effective and efficient, increase innovation and better serve our stakeholders.
*1 Starting from … strategy accordingly.
The business environment in which we operate is also influenced by government health care policies. While medical innovation
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
and digital technologies to improve the quality of innovation and accelerate execution.
Takeda’s pipeline is positioned to support both the near-term … , neurodegenerative diseases and movement disorders.
Oncology
In Oncology, we aspire to cure cancer, with inspiration from patients and innovation from
6-K
EX-99.1
6a37cl
14 Dec 23
Current report (foreign)
6:01am
6-K
EX-99.1
jb1 lle73
30 Nov 23
Current report (foreign)
6:01am
6-K
ydfcwszs
13 Nov 23
Current report (foreign)
6:05am
6-K
rxwo uavz1agq9qjx0
30 Oct 23
Current report (foreign)
6:02am
6-K
ovqmk3z6wy3 cg407s5
1 Aug 23
Current report (foreign)
6:10am
6-K
EX-99.1
r55dviqdlu88t3pj66
12 Jul 23
Current report (foreign)
6:07am
6-K
EX-99.1
7z2utgo94 lul1y4uq
6 Jul 23
Current report (foreign)
6:18am
6-K
EX-99.1
1l217j
23 Jun 23
Current report (foreign)
6:13am
6-K
6c3muj4q8uzr y3tb1
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
lh5kq9l240eihd
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
giqmusd
30 May 23
Current report (foreign)
6:11am
6-K
3x31 030ye
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
zllw2li1m
21 Dec 22
Current report (foreign)
6:01am
6-K
v9drqqjj6 xx41dek
21 Dec 22
Current report (foreign)
6:01am